Cargando…

One hundred and twelve infected arthroplasties treated with ‘DAIR’ (debridement, antibiotics and implant retention): antibiotic duration and outcome

OBJECTIVES: We describe treatment failure rates by antibiotic duration for prosthetic joint infection (PJI) managed with debridement, antibiotics and implant retention (DAIR). METHODS: We retrospectively collected data from all the cases of PJI that were managed with DAIR over a 5 year period. Surgi...

Descripción completa

Detalles Bibliográficos
Autores principales: Byren, I., Bejon, P., Atkins, B. L., Angus, B., Masters, S., McLardy-Smith, P., Gundle, R., Berendt, A.
Formato: Texto
Lenguaje:English
Publicado: Oxford University Press 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2680346/
https://www.ncbi.nlm.nih.gov/pubmed/19336454
http://dx.doi.org/10.1093/jac/dkp107
_version_ 1782166946947530752
author Byren, I.
Bejon, P.
Atkins, B. L.
Angus, B.
Masters, S.
McLardy-Smith, P.
Gundle, R.
Berendt, A.
author_facet Byren, I.
Bejon, P.
Atkins, B. L.
Angus, B.
Masters, S.
McLardy-Smith, P.
Gundle, R.
Berendt, A.
author_sort Byren, I.
collection PubMed
description OBJECTIVES: We describe treatment failure rates by antibiotic duration for prosthetic joint infection (PJI) managed with debridement, antibiotics and implant retention (DAIR). METHODS: We retrospectively collected data from all the cases of PJI that were managed with DAIR over a 5 year period. Surgical debridement, microbiological sampling, early intravenous antibiotics and prolonged oral follow-on antibiotics were used. RESULTS: One hundred and twelve cases of PJI were identified. Twenty infections (18%) recurred during a mean follow-up of 2.3 years. The mean duration of antibiotic use was 1.5 years. Failure was more common after arthroscopic debridement, for previously revised joints and for Staphylococcus aureus infection. There were 12 failures after stopping antibiotics and 8 while on antibiotics [hazard ratio (HR) = 4.3, 95% confidence interval (CI) 1.4–12.8, P = 0.01]. However, during the first 3 months of follow-up, there were eight failures after stopping antibiotics and two while on antibiotics (HR = 7.0, 95% CI 1.5–33, P = 0.015). The duration of antibiotic therapy prior to stopping did not predict outcome. CONCLUSIONS: PJI may be managed by DAIR. The risk of failure with this strategy rises after stopping oral antibiotics, but lengthening antibiotic therapy may simply postpone, rather than prevent, failure.
format Text
id pubmed-2680346
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-26803462009-05-12 One hundred and twelve infected arthroplasties treated with ‘DAIR’ (debridement, antibiotics and implant retention): antibiotic duration and outcome Byren, I. Bejon, P. Atkins, B. L. Angus, B. Masters, S. McLardy-Smith, P. Gundle, R. Berendt, A. J Antimicrob Chemother Original Research OBJECTIVES: We describe treatment failure rates by antibiotic duration for prosthetic joint infection (PJI) managed with debridement, antibiotics and implant retention (DAIR). METHODS: We retrospectively collected data from all the cases of PJI that were managed with DAIR over a 5 year period. Surgical debridement, microbiological sampling, early intravenous antibiotics and prolonged oral follow-on antibiotics were used. RESULTS: One hundred and twelve cases of PJI were identified. Twenty infections (18%) recurred during a mean follow-up of 2.3 years. The mean duration of antibiotic use was 1.5 years. Failure was more common after arthroscopic debridement, for previously revised joints and for Staphylococcus aureus infection. There were 12 failures after stopping antibiotics and 8 while on antibiotics [hazard ratio (HR) = 4.3, 95% confidence interval (CI) 1.4–12.8, P = 0.01]. However, during the first 3 months of follow-up, there were eight failures after stopping antibiotics and two while on antibiotics (HR = 7.0, 95% CI 1.5–33, P = 0.015). The duration of antibiotic therapy prior to stopping did not predict outcome. CONCLUSIONS: PJI may be managed by DAIR. The risk of failure with this strategy rises after stopping oral antibiotics, but lengthening antibiotic therapy may simply postpone, rather than prevent, failure. Oxford University Press 2009-06 2009-03-31 /pmc/articles/PMC2680346/ /pubmed/19336454 http://dx.doi.org/10.1093/jac/dkp107 Text en © The Author 2009. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org
spellingShingle Original Research
Byren, I.
Bejon, P.
Atkins, B. L.
Angus, B.
Masters, S.
McLardy-Smith, P.
Gundle, R.
Berendt, A.
One hundred and twelve infected arthroplasties treated with ‘DAIR’ (debridement, antibiotics and implant retention): antibiotic duration and outcome
title One hundred and twelve infected arthroplasties treated with ‘DAIR’ (debridement, antibiotics and implant retention): antibiotic duration and outcome
title_full One hundred and twelve infected arthroplasties treated with ‘DAIR’ (debridement, antibiotics and implant retention): antibiotic duration and outcome
title_fullStr One hundred and twelve infected arthroplasties treated with ‘DAIR’ (debridement, antibiotics and implant retention): antibiotic duration and outcome
title_full_unstemmed One hundred and twelve infected arthroplasties treated with ‘DAIR’ (debridement, antibiotics and implant retention): antibiotic duration and outcome
title_short One hundred and twelve infected arthroplasties treated with ‘DAIR’ (debridement, antibiotics and implant retention): antibiotic duration and outcome
title_sort one hundred and twelve infected arthroplasties treated with ‘dair’ (debridement, antibiotics and implant retention): antibiotic duration and outcome
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2680346/
https://www.ncbi.nlm.nih.gov/pubmed/19336454
http://dx.doi.org/10.1093/jac/dkp107
work_keys_str_mv AT byreni onehundredandtwelveinfectedarthroplastiestreatedwithdairdebridementantibioticsandimplantretentionantibioticdurationandoutcome
AT bejonp onehundredandtwelveinfectedarthroplastiestreatedwithdairdebridementantibioticsandimplantretentionantibioticdurationandoutcome
AT atkinsbl onehundredandtwelveinfectedarthroplastiestreatedwithdairdebridementantibioticsandimplantretentionantibioticdurationandoutcome
AT angusb onehundredandtwelveinfectedarthroplastiestreatedwithdairdebridementantibioticsandimplantretentionantibioticdurationandoutcome
AT masterss onehundredandtwelveinfectedarthroplastiestreatedwithdairdebridementantibioticsandimplantretentionantibioticdurationandoutcome
AT mclardysmithp onehundredandtwelveinfectedarthroplastiestreatedwithdairdebridementantibioticsandimplantretentionantibioticdurationandoutcome
AT gundler onehundredandtwelveinfectedarthroplastiestreatedwithdairdebridementantibioticsandimplantretentionantibioticdurationandoutcome
AT berendta onehundredandtwelveinfectedarthroplastiestreatedwithdairdebridementantibioticsandimplantretentionantibioticdurationandoutcome